Switch to:
More From Other Websites
Most active Nasdaq-traded stocks Sep 02 2014
Most active Nasdaq-traded stocks Sep 02 2014
Exelixis Plunges On Drug Trial Failure; Investors See Potential Sep 02 2014
US STOCKS-Wall St little changed after August rally, data Sep 02 2014
After the Exelixis Implosion, Is There Anything Left Ahead? Sep 02 2014
Why Exelixis (EXEL) Stock Plunged to a One-Year Low Today Sep 02 2014
Exelixis Drug Fails Pivotal Prostate Cancer Study Sep 02 2014
Fight for Family Dollar heats up; Tesla powers ahead; Exelixis tanks Sep 02 2014
Ahead of the Bell: Exelixis shares tumble Sep 02 2014
Ahead of the Bell: Exelixis shares tumble Sep 02 2014
US STOCKS-Wall St set for flat open; manufacturing data on tap Sep 02 2014
US STOCKS-Wall St set for flat open; manufacturing data on tap Sep 02 2014
Exelixis downgraded by Stifel Sep 02 2014
US STOCKS-Futures inch higher ahead of manufacturing data Sep 02 2014
US STOCKS-Futures inch higher ahead of manufacturing data Sep 02 2014
6:47 am Correction: Exelixis announces results from the COMET-1 Phase 3 pivotal trial of... Sep 02 2014
Exelixis to cut jobs after prostate cancer drug fails late-stage study Sep 01 2014
Exelixis to cut jobs after prostate cancer drug fails late-stage study Sep 01 2014
Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with... Sep 01 2014
EXELIXIS, INC. Financials Aug 08 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK